Attached files

file filename
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Horizon Therapeutics Public Ltd Cods1a.htm
EX-4.10 - INVESTORS' RIGHTS AGREEMENT - Horizon Therapeutics Public Ltd Codex410.htm
EX-10.29 - SALES CONTRACT - Horizon Therapeutics Public Ltd Codex1029.htm
EX-23.2 - CONSENT OF ERNST & YOUNG LTD. - Horizon Therapeutics Public Ltd Codex232.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Amendment No. 2 to the Registration Statement on Form S-1 of our report dated August 3, 2010, relating to the consolidated financial statements of Horizon Pharma, Inc., (formerly Horizon Therapeutics, Inc.), which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/    PRICEWATERHOUSECOOPERS LLP

PricewaterhouseCoopers LLP

San Jose, California

October 8, 2010